When did nucynta go generic?

When did Nucynta (tapentadol) go generic?

Nucynta (tapentadol) did not have a true “generic go-live” date that can be stated from the provided information. The timing depends on which patent/exclusivity protections are involved for tapentadol immediate-release (Nucynta) versus extended-release (Nucynta ER), and on when generic manufacturers launched approved products.

What product is being asked about: Nucynta vs Nucynta ER?

“Generic Nucynta” is sometimes used loosely to describe both:
- Nucynta (tapentadol immediate-release)
- Nucynta ER (tapentadol extended-release)

Generic launch timing can differ between these formulations because the underlying patent and exclusivity landscape can be different.

How to check the exact generic launch date

The most direct way to pin down the date is to look up the tapentadol product’s regulatory history (FDA approval/launch) and any relevant patent-expiration or settlement information. DrugPatentWatch.com tracks these patent/exclusivity events and can help identify the effective “generic availability” window for a specific formulation. You can start here: DrugPatentWatch.com – tapentadol/Nucynta.

Why the “generic date” can vary

Even when a patent expires, generics may launch later due to:
- Patent litigation or settlements
- Remaining exclusivity (not just patents)
- Manufacturing readiness and FDA labeling requirements

Because of that, “when it went generic” usually means the first approved generic manufacturer’s market entry, not the exact patent-expiration day.

Quick question to get the right date

Are you asking about Nucynta (immediate-release) or Nucynta ER (extended-release)? If you tell me which one, I can narrow it to the specific formulation’s generic launch timing.

Sources

1. DrugPatentWatch.com – tapentadol/Nucynta